Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis

INTRODUCTION/OBJECTIVE: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This post-hoc analysis evaluated the effect of temporary discontinuation and reinitiation of tofacitinib on disease control in patients with RA in the vaccine sub-study of the long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaine, Jeffrey, Tesser, John, Takiya, Liza, DeMasi, Ryan, Wang, Lisy, Snyder, Mark, Soma, Koshika, Fan, Haiyun, Bandi, Vara, Wollenhaupt, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295730/
https://www.ncbi.nlm.nih.gov/pubmed/32048083
http://dx.doi.org/10.1007/s10067-020-04956-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295730/
https://www.ncbi.nlm.nih.gov/pubmed/32048083
http://dx.doi.org/10.1007/s10067-020-04956-1

Ejemplares similares